Outcome of Full Pulpotomy Using Calcium Silicate Based Materials

NCT ID: NCT04345263

Last Updated: 2024-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-01

Study Completion Date

2024-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Permanent teeth with carious pulp exposure and indicated for full pulpotomy will be treated using three different materials using aseptic technique and will be subsequently followed up clinically and radiographically at 6 months, 1 year and yearly up to 5 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* The target sample size is 150 patients medically fit, having vital teeth with carious pulp exposure and complaining of pain.
* The patients tooth will receive full pulpotomy under aseptic conditions and it will be randomly assigned to one of 3 calcium silicate based materials namely, (Mineral trioxide Aggregate (MTA), Biodentine, and Bioceramic for capping the full pulpotomy followed by resin composite restoration.
* Follow up for pain levels will be done during the first week.
* clinical and radiographic examination will be done at 6 months, 1 year and yearly up to 5 years.
* Success of the procedure includes absence of clinical signs and symptoms, with absence of pathology in the root and periapex on periapical radiographs.
* The 3 materials will be compared in terms of clinical and radiographic outcomes.
* demographic data of the three groups will be also compared
* predictive factors of success will be also analyzed
* tooth color changes will be also measured using vita easy shade and will compared between the groups at 6 months and 1 year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carious Teeth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Patient unaware of the material to be used, care provider will be given the material after performing full pulpotomy . Tooth crown will be masked during assessment of radiographs

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MTA pulpotomy

Tooth will receive MTA \& resin composite restoration

Group Type ACTIVE_COMPARATOR

MTA pulpotomy

Intervention Type PROCEDURE

Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration

Biodentine pulpotomy

Tooth will receive Biodentine \& resin composite restoration

Group Type ACTIVE_COMPARATOR

MTA pulpotomy

Intervention Type PROCEDURE

Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration

Bioceramic pulpotomy

Tooth will receive Bioceramic \& resin composite restoration

Group Type ACTIVE_COMPARATOR

MTA pulpotomy

Intervention Type PROCEDURE

Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MTA pulpotomy

Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Biodentine pulpotomy and Bioceramic pulpotomy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mature permanent tooth with carious lesion exposing the pulp,
* Positive response to cold test
* Clinical Diagnosis of reversible or irreversible pulpitis
* Restorable tooth by direct restoration or crown
* Healthy patient

Exclusion Criteria

* Non vital teeth
* Teeth without pulp exposure
* Inability to achieve hemostasis within 10 min after pulpotomy
* Non restorable teeth or teeth that require post and core restoration
Minimum Eligible Age

16 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jordan University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nessrin Taha, DCD

Role: STUDY_CHAIR

Jordan University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dental teaching centre Faculty Of Dentistry

Irbid, , Jordan

Site Status

Jordan University of science and technology

Irbid, , Jordan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Jordan

References

Explore related publications, articles, or registry entries linked to this study.

Taha NA, Al-Rawash MH, Imran ZA. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate-based materials: A parallel, double blind, randomized controlled trial. Int Endod J. 2022 May;55(5):416-429. doi: 10.1111/iej.13707. Epub 2022 Mar 17.

Reference Type DERIVED
PMID: 35152464 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

503/2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.